One of the most compelling stories in MedTech.
NeedleSmart is the world's first digital end-to-end injection management platform. It was built to optimize both the patient and clinical experiences, bringing together a process and workflow that makes sense for all.
The NeedleSmart technology brings process to injections/vaccinations, making the event more efficient, cost-effective, accurate, safer, and environmentally sustainable. By combining safe, environmentally sound hypodermic needle disposal with workflow efficiencies, we have created a fast, scalable, and compliant digital treatment and event record system that is changing the game for healthcare professionals and patients.
For more information and booking opportunities, please contact Jillfrances Gray, Director of Marketing.
Michael Barron and Cliff Kirby of NeedleSmart
Recent Appearances
Innovation Solutions To Streamlining Healthcare Workflows
The Health Innovators Show
Dr. Roxie Mooney
July, 2024
In this episode of Health Innovators, Dr. Roxy Mooney interviews Cliff Kirby, CEO, and Michael Baron, COO. They discuss their non-traditional paths into healthcare innovation, focusing on enhancing efficiency in medical processes. NeedleSmart aims to revolutionize injection therapy through innovative hardware and software solutions. They highlight the importance of community-building, collaboration, and strategic partnerships. The conversation covers the seven steps to product launches, challenges faced by startups, the significance of the right board of advisors, and the disciplined approach NeedleSmart uses in its commercialization strategy, with upcoming projects involving government agencies like the Veterans Administration.
Injection Management 2.0: A Safer, Efficient, and Sustainable Approach with NeedleSmart
Daily Healthcare Insights Podcast
Saul Marquez, Outcomes Rocket
February, 2024
In this episode of Outcomes Rocket, Saul Marquez hosts Cliff Kirby, CEO, and Michael Barron, COO. NeedleSmart is revolutionizing injection delivery with its digital end-to-end management platform, which enhances safety, efficiency, and data hygiene in clinical settings. This episode delves into their backgrounds, the company’s innovative approach to injection management, the challenges they faced during COVID-19, and the role of AI in healthcare. Key benefits include reducing needle stick injuries, optimizing clinical workflows, and improving data-driven healthcare outcomes.
Digital Assets and Resources
Digital assets includes About NeedleSmart Content, Profile headshots and bios.
Cliff Kirby, CEO
Cliff Kirby has spent his career in the world of business, engineering, and product development. He graduated with a degree in Mechanical Engineering in 2002 and, in 2003, established an Engineering Design Consultancy.
Cliff has developed an end-to-end product development and delivery approach by working with and alongside blue-chip companies such as Rolls Royce, Caterpillar, Tyco Inc, 3M, and Paccar.
Building strong working relationships with all clients, he is able to create unique working partnerships that see him take direct responsibility for turnkey projects and new product launches.
Understanding intrinsically the development process, Cliff has successfully delivered numerous new products to market for global clients, leading multi-disciplined teams in all aspects of product development and launch to market.
Michael Barron, COO
Michael Barron is a Philadelphia-based graduate of Villanova University. He has spent the last 30 years helping to build, scale, and lead high-growth companies. The first 20 years of his career were spent building and managing portfolios for family offices and sovereign wealth funds.
Having spent the first 20 years looking at investment opportunities for clients, Michael took the bold step of switching lanes to work directly with SMEs across a variety of market sectors in an operational capacity. As an investor and executive, he has led multiple investment firms to over $1B in assets from inception.
Michael has been featured in The Wall Street Journal and Investors Business Daily. He has been a regular guest on Bloomberg and CNBC.
Michael is also a board member at The Foreign Policy Research (USA) Institute and The Satell Institute (USA).